MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-HR-13-0001800
Daksh Pharmaceuticals Private Limited - pharma in Jodhpur, Rajasthan, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹19.76 Cr
▼ 2% YoY
Net profit · FY 2025
₹1.21 Cr
Net margin 6.1%
EBITDA · FY 2025
₹2.97 Cr
EBITDA margin 15%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹8.9 Lakh
Issued & subscribed
Open charges
₹17.38 Cr
Satisfied ₹30 Lakh
Company age
20 yrs
Est. 2006
Directors on board
2
As per MCA filings
About Daksh Pharmaceuticals Private Limited
Data last updated:
Daksh Pharmaceuticals Private Limited is a private limited company based in Jodhpur, Rajasthan, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 17 October 2006 and has been in existence for over 20 years.
The company is registered with the Registrar of Companies (ROC), Jaipur, under CIN U24232RJ2006PTC023241. Its GSTIN is 08AACCD4698J1Z6 (Rajasthan). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹8.9 Lakh. It is led by directors Madhubala Agarwal and Ajay Agarwal.
Its last annual general meeting (AGM) was held on 29 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 326 Iiird Floor Razdan Mansion Jalori Bari, Jodhpur, Rajasthan, India – 342001.
As per the financials filed for FY 2025, the company reported a revenue of ₹19.76 Cr, a decline of 2% compared to the previous year. For the same year it recorded a net profit of ₹1.21 Cr (net margin 6.1%) and EBITDA of ₹2.97 Cr (EBITDA margin 15%). Revenue has declined at a compounded annual rate (CAGR) of 4% over three years and 1% over five years.
Its group structure includes 1 subsidiary.
The company is associated with 1 brand: Daksh Pharma. As per MCA filings, the company has open charges of ₹17.38 Cr and satisfied charges of ₹30 Lakh on record. Court records list 18 cases involving the company, including 13 filed by the company and 5 filed against it; 2 cases are pending.
Daksh Pharmaceuticals Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-HR-13-0001800). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website dakshgroup.net.
Company details
CIN U24232RJ2006PTC023241
Registration Number 023241
Incorporation Date 17 October 2006
ROC Jaipur
Listing Status Unlisted
Company Status Active
Date of Last AGM 29 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-HR-13-0001800
Key People
Madhubala Agarwal Director Ajay Agarwal Director Recognitions & Rankings of Daksh Pharmaceuticals
Contact details
Daksh Pharmaceuticals Private Limited's registered office is in Jodhpur, Rajasthan. Its website is dakshgroup.net. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address326 Iiird Floor Razdan Mansion Jalori Bari, Jodhpur, Rajasthan, India – 342001
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Daksh Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Daksh Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Daksh Pharmaceuticals operates one associated brand: Daksh Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Provides quality pharmaceutical products, manufacturing, and franchise opportunities in India. | dakshpharma.com |
Business activity
The main business activity of Daksh Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Daksh Pharmaceuticals Private Limited, buy the company report.
Financials of Daksh Pharmaceuticals Private Limited
FY 2024 filings availableDaksh Pharmaceuticals Private Limited reported revenue of ₹19.76 Cr (down 2% YoY) for FY 2025.
Revenue · FY 2025
₹19.76 Cr ▼ 2%
Net profit · FY 2025
₹1.21 Cr margin 6.1%
EBITDA · FY 2025
₹2.97 Cr margin 15%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 2%
3 years · compounded
▼ 4%
5 years · compounded
▼ 1%
EBITDA CAGR growth
1 year
▲ 10%
3 years · compounded
▲ 12%
5 years · compounded
▲ 5%
Revenue has declined at a compounded annual rate (CAGR) of 1% over five years, including a 2% fall in the latest year. EBITDA rose 10% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.97 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.21 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 15% | ||||
| Net Profit Margin | 6.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Daksh Pharmaceuticals Private Limited, buy the company report.
Board of directors of Daksh Pharmaceuticals Private Limited
Daksh Pharmaceuticals has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Madhubala Agarwal Also directs: Zodley Pharmaceuticals Private Limited | Director | 17 Oct 2006 | 20 Years 0 Months | Current |
| Ajay Agarwal | Director | 17 Oct 2006 | 20 Years 0 Months | Current |
Peer comparison
Daksh Pharmaceuticals Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Raja Tradelinks Private Limited | ₹19.9 Cr (FY 2025) | 42.0% | Mumbai, Maharashtra, India | |||
| Creation Medicare Private Limited | ₹19.89 Cr (FY 2025) | 68.0% | Kolkata, West Bengal, India | |||
| Op Pharma Distributor Private Limited | ₹19.82 Cr (FY 2023) | -35.0% | Ghaziabad, Uttar Pradesh, India | |||
| Zerico Lifesciences Private Limited | ₹19.79 Cr (FY 2024) | 13.0% | Thane, Maharashtra, India | |||
| Daksh Pharmaceuticals Private Limitedthis company | ₹19.76 Cr (FY 2025) | ₹1.21 Cr | 6.1% | -2.0% | Jodhpur, Rajasthan, India | |
| Vyom Distributors Private Limited | ₹19.64 Cr (FY 2024) | 5.0% | Ghaziabad, Uttar Pradesh, India | |||
| Tamarugatam Pharmaceuticals Private Limited | ₹19.59 Cr (FY 2024) | 3.0% | Chennai, Tamil Nadu, India |
To see the full peer comparison of Daksh Pharmaceuticals Private Limited, buy the company report.
Auditor
Daksh Pharmaceuticals Private Limited is audited by P.K. MEHTA & ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| P.K. MEHTA & ASSOCIATES | FY 2023 | 008742C |
Shareholding
The shareholding of Daksh Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Daksh Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹17.38 Cr
Satisfied charges
₹30 Lakh
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 12 May 2021 | 100447040 | Hdfc Bank Limited | ₹9.38 Cr | Open | |
| 26 Apr 2018 | 100172764 | Others | ₹91 Lakh | Open | |
| 24 Apr 2015 | 10570760 | Hdfc Bank Limited | ₹7.09 Cr | Open | |
| 30 Sep 2010 | 10245907 | Yes Bank Limited | ₹30 Lakh | Satisfied |
To see the full charge records of Daksh Pharmaceuticals Private Limited, buy the company report.
Total charge records: 4 View all charges
Legal cases
Daksh Pharmaceuticals Private Limited has 18 court cases on record: 13 filed by Daksh Pharmaceuticals, 5 filed against it. 2 cases are pending and 16 are disposed.
Total cases
18
Filed by the company
13
Filed against the company
5
Pending
2
Disposed
16
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 9 | 2 | 0 |
| District courts | 8 | 2 | 2 |
| Supreme Court | 1 | 1 | 0 |
Cases on record (5 of 18)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court of Delhi | Commercial suit | Filed against the company by Glaxosmithkline Pharmaceuticals Limited | Disposed |
| District court, Chandigarh | Court case (CS CJ) | Filed against the company by Ms Nectar Lifesciences Limited | Disposed |
| High Court of Delhi | Court case (CS(OS)) | Filed against the company by Alkem Laboratories Ltd | Disposed |
| District court, East, Delhi | Commercial suit | Filed by the company against an individual | Pending |
| District court, Lucknow, Uttar Pradesh | Cheque dishonour complaint | Filed against the company by Ishawani Healthcare Pvt Ltd | Pending |
To see the full case history of Daksh Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Daksh Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Group structure & subsidiaries
Daksh Pharmaceuticals has 1 subsidiary company. This group structure data is as of FY 2023. The table lists each entity with its relationship and holding.
1
Subsidiary companies
Key subsidiaries
| Company Name | CIN | Shares held |
|---|---|---|
| M Sea Pharmaceuticals Private Limited | U74900HP2015PTC000911 |
To see the full group structure of Daksh Pharmaceuticals Private Limited, buy the company report.
GST
Daksh Pharmaceuticals has 2 GST registrations: 2 active.
Total GSTINs
2
Active
2
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 08AACCD4698J1Z6 | Rajasthan | Active | 01 Jul 2017 |
| 06AACCD4698J1ZA | Haryana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Daksh Pharmaceuticals Private Limited, buy the company report.
Recent activity
Daksh Pharmaceuticals Private Limited has 2 board changes on record since 2006: 2 appointments. The latest: Ajay Agarwal was appointed as Director on 17 Oct 2006.
Charges
A charge with Hdfc Bank Limited of Rs. 938.23 Lakh registered on 12 May 2021 with Charge ID 100447040 was modified on 04 Aug 2025.
AGM
Daksh Pharmaceuticals Private Limited last Annual general meeting of members was held on 29 Sep 2024 as per latest MCA records.
Filing
Daksh Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Jaipur.
Charges
A charge with Hdfc Bank Limited of Rs. 708.50 Lakh registered on 24 Apr 2015 with Charge ID 10570760 was modified on 03 Mar 2024.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 938.23 Lakh with Charge ID 100447040 was registered on 12 May 2021.
Charges
A charge with Others amounted to Rs. 91.00 Lakh with Charge ID 100172764 was registered on 26 Apr 2018.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 708.50 Lakh with Charge ID 10570760 was registered on 24 Apr 2015.
Charges
A charge registered on 30 Sep 2010 via Charge ID 10245907 with Yes Bank Limited was fully satisfied on 04 May 2013.
Charges
A charge with Yes Bank Limited amounted to Rs. 30.00 Lakh with Charge ID 10245907 was registered on 30 Sep 2010.
Appointed
Ajay Agarwal was appointed as Director.
Appointed
Madhubala Agarwal was appointed as Director.
Incorporation
17 Oct 2006
Daksh Pharmaceuticals Private Limited was registered on 17 Oct 2006 with Roc Jaipur & aged 20 years 19 days as per MCA records.
Frequently asked questions
Daksh Pharmaceuticals is an active private limited company based in Jodhpur, Rajasthan, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 17 October 2006 (20+ years old) and is registered under CIN U24232RJ2006PTC023241.
Daksh Pharmaceuticals has 2 current directors:
- Madhubala Agarwal - Director
- Ajay Agarwal - Director
The latest financial statements of Daksh Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 29 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Daksh Pharmaceuticals is 08AACCD4698J1Z6, registered in Rajasthan. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 06AACCD4698J1ZA (Haryana).
The CIN (Corporate Identification Number) of Daksh Pharmaceuticals is U24232RJ2006PTC023241. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Daksh Pharmaceuticals has 18 court cases on record: 13 filed by the company and 5 filed against it. 2 are pending. Most are in the high courts.
Daksh Pharmaceuticals was incorporated on 17 October 2006, making it 20+ years old. It is registered with the Registrar of Companies, Jaipur.
The peers of Daksh Pharmaceuticals by revenue are Raja Tradelinks Private Limited, Creation Medicare Private Limited, Op Pharma Distributor Private Limited, Zerico Lifesciences Private Limited, Vyom Distributors Private Limited and 1 more, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading).
Ajay Agarwal was appointed as Director on 17 Oct 2006. Madhubala Agarwal was appointed as Director on 17 Oct 2006.
Yes, Daksh Pharmaceuticals is registered as a small enterprise under Udyam registration (number: UDYAM-HR-13-0001800).
Daksh Pharmaceuticals can be reached through the website dakshgroup.net. Its registered office is in Jodhpur, Rajasthan, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages